Comparative Investigation on in vitro release of extemporaneously prepared norfloxacin semisolid formulations with marketed silver sulfadiazine 1% cream, USP using model independent approach

Ars Pharmaceutica

Volumn 51, Issue 4, 2010, Pages 177-185

  Dua, K ^a   Pabreja, K ^a   Ramana, M V ^b  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b VIT UNIVERSITY   (India)

Author keywords

Norfloxacin; Ointments; Semisolid

Indexed keywords

NORFLOXACIN; SULFADIAZINE SILVER;

ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; IN VITRO STUDY; NONHUMAN; RAT; SKIN PERMEABILITY;

EID: 79953660641     PISSN: 00042927     EISSN: 00042927     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Benner MW, Bencon PM and. James WD, In; Topical Antibiotics in Dermatology, 5th Ed., McGraw Hill, 1999, 25-27. NY
2. Murakawa GJ and Sable D. Quinolones in Dermatology. Clinical Dermatol., 21(1) (2003) pp. 56-63.
3. Martindale, The Extra Pharmacopoeia, 29th Ed., Reynolds, J.E.F.(Eds.),The Pharmaceutical Press, London (1989).
4. Rathore YKS, Chatterjee PK, Mathur S, Sunderlal C and Sethi PD. Indian Drugs 27 (1990) 215-217.
5. Florey K. Analytical Profiles of Drug Substances, Academic Press, Inc., 1991, Vol. 20, pp. 557-600. New York
6. Rajni V and Verma PRP. Diffusion study of ibuprofen from ointment base. Ind. J. Pharm. Sci. 57 (1995) 1-6.
7. Mohammed A, Yasmin S. and Asgar A., Matrix type transdermal drug delivery systems of metoprolol tartrate, Acta. Pharm. 53 (2003) 119-125.
8. Ezzedeen FW, Shihab FA and Husain EJ, Percutanous diffusion of cefalexin, sulfamethoxazole and diphenhydramine from ointments. Pharmazie 45 (1990) 512-514. (Pubitemid 20266566)
9. Sanna V, Peana AT. and Moretti MD. Effect of vehicle on diclofenac sodium permeation from new topical formulations: in vitro and in vivo studies. Curr Drug Deliv. 6(1) (2009) 93-100.
10. Nagia AE, Hanan ME and Gehan FB. Formulation and evaluation of meloxicam gels for topical administration. Saudi Pharm. J. 14(3-4) (2006) 155-62.
11. Singh S, Gajra B, Rawat M and Muthu MS. Enhanced transdermal delivery of ketoprofen from bioadhesive gels. Pak J Pharm Sci 22(2) (2009) 193-198.
12. Moore JW and Flanner HH. Mathematical comparison of dissolution profiles. Pharm Technol 20 (1996) 64-74. (Pubitemid 126450495)
13. Costa P and Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 13 (2001)123-133. (Pubitemid 32288781)
14. FDA, Guidance for industry: dissolution testing of immediate release solid oral dosage forms, (BP1), Centre for drug evaluation and research, Food and drug administration, 1997, Rockville, MD, P9. http://www.fda.gov/cder/ guidance.
15. Parikh NH, Babar A and Plakogiannis FM. Medicament release from ointment bases: II. Testosterone: in vitro release and effects of additives on its release. Drug Development and Industrial Pharmacy 12(14) (1986) 2493-2509.
16. B. Perez-Marcos R. Iglesias and Gomez-Amoxa JL. Mechanical and drug release properties of atenolol-Carbopol hydrophilic matrix tablets. J Controlled Rel 17(3) (1991) 267-276.
17. Dhavse VV and Amin PD. Formulation and evaluation of topical bases of ketoprofen. East Pharm. (1997) 133-135.